Clinical Study

Use of Nebulized Amphotericin B in the Treatment of Allergic Bronchopulmonary Aspergillosis in Cystic Fibrosis

Table 2

Different formulation of amphotericin B.

Formul-
ation
CarrierColloidal typeSize (μm)Molar ratio

AMB-dDeoxycholateMicelle0.035
L-AMBPC/DSPG/CholLiposome0.082 : 0. 8 : 1 : 0. 4
ABLCPhospholipidsLipid ribbon1.6–111 : 1
ABCDCholesteryl sulphateLipid disk0.11-0.121 : 1

PC: phosphatidylcholine; DSPG: distearoylphosphatidylglycerol; Chol: cholesterol.